Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
Authors
Keywords
-
Journal
ACS Medicinal Chemistry Letters
Volume 13, Issue 1, Pages 140-147
Publisher
American Chemical Society (ACS)
Online
2021-09-30
DOI
10.1021/acsmedchemlett.1c00299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An in silico analysis of Ibuprofen enantiomers in high concentrations of sodium chloride with SARS-CoV-2 main protease
- (2021) C. M. Clemente et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
- (2021) Gordon J. Lockbaum et al. Viruses-Basel
- Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies
- (2021) Rajarshi Roy et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
- (2021) Jingxin Qiao et al. SCIENCE
- Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
- (2021) Chun-Hui Zhang et al. ACS Central Science
- X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
- (2021) Sebastian Günther et al. SCIENCE
- Synthesis of Novel Azides and Triazoles on the Basis of 1н-Pyrazole-3(5)-Carboxylic Acids
- (2020) Aleksander I. Dalinger et al. Chemistry of Heterocyclic Compounds
- Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target
- (2020) Umesh et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
- (2020) Junmei Wang Journal of Chemical Information and Modeling
- Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
- (2020) Davide Gentile et al. Marine Drugs
- Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
- (2020) Anh-Tien Ton et al. Molecular Informatics
- Materials science approaches in the development of broad-spectrum antiviral therapies
- (2020) Nam Joon Cho et al. NATURE MATERIALS
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
- (2020) Zhenming Jin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
- (2020) Mahmoud Kandeel et al. LIFE SCIENCES
- Bispidine-based bis-azoles as a new family of supramolecular receptors: the theoretical approach
- (2020) Sergey Z. Vatsadze et al. MENDELEEV COMMUNICATIONS
- Molecular foundations of COVID-19 pathogenesis
- (2020) F N Novikov et al. RUSSIAN CHEMICAL REVIEWS
- 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice
- (2020) Athri D. Rathnayake et al. Science Translational Medicine
- The SARS-CoV-2 main protease as drug target
- (2020) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals
- (2020) Daniel W. Kneller et al. STRUCTURE
- Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2020) Wayne Vuong et al. Nature Communications
- A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**
- (2020) Kai S. Yang et al. ChemMedChem
- Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface
- (2020) Julia Liang et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Supramolecular Organogels Based on N-Benzyl, N′-Acylbispidinols
- (2019) Alexey Medved’ko et al. Nanomaterials
- Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms
- (2018) Wei Wang et al. CARCINOGENESIS
- Bispidine as a Privileged Scaffold
- (2016) Isabelle Tomassoli et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Conformational Study of N,N′-Diacyl Bispidines and Dioxo Bis-bispidines: Planar Chirality and Molecular Switching
- (2016) Zhuo Wang et al. JOURNAL OF ORGANIC CHEMISTRY
- Computer modeling of ferrocene-substituted 3,7-diazabicyclo[3.3.1]nonanes as serine protease inhibitors
- (2016) Sergey Z. Vatsadze et al. MENDELEEV COMMUNICATIONS
- New supramolecular synthons based on 3d transition metal complexes with bidentate bispidines: synthesis and structural, spectroscopic, and electrochemical studies
- (2015) S. Z. Vatsadze et al. RUSSIAN CHEMICAL BULLETIN
- Synthesis of novel bridged dinitrogen heterocycles and their evaluation as potential fragments for the design of biologically active compounds
- (2014) Konstantin V. Kudryavtsev et al. TETRAHEDRON
- Bispidine-Amino Acid Conjugates Act as a Novel Scaffold for the Design of Antivirals That Block Japanese Encephalitis Virus Replication
- (2013) V. Haridas et al. PLoS Neglected Tropical Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now